Quankun Lv | Health Professions | Best Researcher Award

Published on by Best Paper Awards

Best Researcher Award

Quankun Lv  | The Sixth Affiliated Hospital, School of Medicine, South China University of Technology | China

Quankun Lv
Affiliation The Sixth Affiliated Hospital, School of Medicine, South China University of Technology
Country China
Subject area Health Professions
Event International Research Excellence and Best Paper Awards
ORCID 0009-0000-6110-0855

Quankun Lv is a researcher affiliated with The Sixth Affiliated Hospital, School of Medicine, South China University of Technology, China. The researcher’s scholarly record includes publications in critical care prediction and cancer research. These publications provide identifiable evidence of research activity in healthcare-related fields. This profile summarises the available identifying information and selected research outputs while distinguishing documented publication records from award-related claims. The ORCID identifier provides a persistent link for checking the researcher’s scholarly identity and associated publications. [1] [5] [6]

Abstract

This article presents a research profile for Quankun Lv, whose published work identifies an affiliation with The Sixth Affiliated Hospital, School of Medicine, South China University of Technology, China. The available publisher and bibliographic records identify research contributions involving prognostic modelling in intensive care and mechanisms of chemoresistance in lung adenocarcinoma. These publications provide a basis for documenting the researcher’s scholarly activity in healthcare and medical research. Publication details can be checked through the journal publisher and PubMed records. No specific award outcome, citation count, or h-index is asserted here without independent evidence. [1] [5] [6]

Keywords

  • Quankun Lv
  • Health Professions
  • Critical care research
  • Prognostic modelling
  • Cancer research
  • Lung adenocarcinoma
  • Academic publications
  • Research assessment

Introduction

Researcher profiles help readers identify scholarly publications, institutional affiliations, and contributions to a particular field. In medical and health-related disciplines, the assessment of research requires consideration of study design, methodological quality, reproducibility, clinical relevance, and the accuracy of publication attribution. An individual’s research record should be established through authoritative journal pages and bibliographic databases rather than inferred solely from an institutional affiliation or a name match. [2] [3]

Research Profile

The available publisher and PubMed records identify Quankun Lv as an author affiliated with The Sixth Affiliated Hospital, School of Medicine, South China University of Technology, in Foshan, Guangdong, China. The indexed records associate the author with work on intensive care prognostic prediction and lung adenocarcinoma research. These subject areas indicate participation in medical research, but they should not be treated as a complete description of the researcher’s expertise or professional responsibilities. The linked ORCID record provides an additional means of checking the author’s scholarly identity. [1] [5] [6]

Research Contributions

One identifiable publication examines whether an apparent transition to persistent critical illness remains consistent when clinical states are updated daily across two intensive care databases. The study evaluates prognostic modelling and compares findings across datasets. Another publication investigates the relationship between cancer-associated fibroblasts and chemotherapy resistance in lung adenocarcinoma, identifying a proposed PLAU-positive fibroblast signalling pathway associated with reduced drug sensitivity. Together, these publications cover distinct clinical research questions and demonstrate contributions to collaborative medical research. The conclusions and author details should be interpreted using the original articles. [5] [6]

Publications

The following publications have identifiable bibliographic records that list Quankun Lv among the authors. The first is indexed by PubMed and has a DOI record. The second is published in Cancer Research and has an official publisher page. Author order, article metadata, and publication status should be checked against the linked records before the details are reused in formal academic documents. [5] [6]

Research Impact

Research impact can be assessed through several dimensions, including scholarly citations, methodological influence, relevance to clinical practice, and the use of findings by other researchers. Citation counts and other bibliometric indicators may help describe the visibility of a publication, but they cannot independently establish the quality or practical value of the underlying research. Responsible assessment should consider the scientific content of the work alongside relevant quantitative and qualitative evidence. [2] [3]

Award Suitability

The supplied award programme is the International Research Excellence and Best Paper Awards. Its website describes recognition associated with research publications and scholarly contributions. However, the existence of publications does not establish that a researcher has won an award or been formally selected as a laureate. Any assessment of Quankun Lv’s eligibility or suitability should be based on the programme’s current criteria, the nominated publication, the applicant’s contribution, and the authenticity of the supporting documents. No award result is claimed by this profile. [4]

Conclusion

The available bibliographic records provide a basis for documenting Quankun Lv’s research activity in healthcare, including work on intensive care prognostic prediction and lung adenocarcinoma chemoresistance. The linked ORCID record, PubMed entry, and journal publisher page offer verifiable starting points for confirming identity and publication details. Further assessment of research impact or award suitability should rely on documented evidence, transparent criteria, and the official award programme’s published information. [1] [5] [6]

References

  1. ORCID. (n.d.). Quankun Lv — ORCID researcher record. The persistent researcher identifier and associated record can be consulted to verify scholarly identity and linked works.
    https://orcid.org/0009-0000-6110-0855
  2. San Francisco Declaration on Research Assessment (DORA). (n.d.). Read the Declaration. Recommendations on assessing research based on scientific content and a broad range of research outputs rather than relying solely on journal-level metrics.
    https://sfdora.org/read/
  3. San Francisco Declaration on Research Assessment (DORA). (n.d.). Frequently Asked Questions. Background on research assessment and the importance of considering research quality, value, relevance, and diverse contributions.
    https://sfdora.org/faq/
  4. International Research Excellence and Best Paper Awards. (n.d.). Official award website. Consult the programme’s official website for its published event information, categories, criteria, and nomination process. This reference does not independently establish that the researcher named in this profile received an award.
    https://bestpaperawards.com/
  5. Wu, G., Lv, Q., Ye, Y., Yang, Q., Wu, Y., Huo, J., Yang, B., Quan, Z., Huang, Z., Cai, Y., & Guan, Z. (2026). Assessing the consistency of a prognostic transition to persistent critical illness across two U.S. ICU databases: a daily risk-set analysis. International Journal of Medical Informatics, 223, Article 106759. DOI: 10.1016/j.ijmedinf.2026.106759. PubMed record.
    https://pubmed.ncbi.nlm.nih.gov/42854465/
  6. Li, S., Zhang, Z., Lv, Q., Cao, Y., Song, C., Liang, J., Qi, Y.-F., Duan, Z., Wang, Y., & Chen, Y.-G. (2026). A paired tumor organoid-stroma biobank reveals PLAU⁺ fibroblasts as drivers of chemoresistance in lung adenocarcinoma. Cancer Research. DOI: 10.1158/0008-5472.CAN-26-1323. Official journal publisher record.
    https://doi.org/10.1158/0008-5472.CAN-26-1323

Dilek Soylu | Health Professions | Best Researcher Award

Published on by Best Paper Awards

Assoc. Prof. Dr. Dilek Soylu | Health Professions | Best Researcher Award 

Academician | Kahramanmaraş Sütçü İmam Universty | Turkey

Assoc. Prof. Dr. Dilek Soylu is a highly accomplished academic whose extensive contributions to surgical nursing, organ transplantation, disaster preparedness, palliative care, and innovative nursing education make her an exceptional candidate for a Best Researcher Award. With a PhD in Surgical Nursing from Erciyes University and strong foundational training through both thesis and non-thesis master’s programs, she has built a career that integrates rigorous scientific inquiry with over a decade of hands-on clinical experience as an organ transplant coordinator and surgical intensive care nurse. This dual perspective strengthens the clinical applicability and societal relevance of her research. Assoc. Prof. Dr. Soylu has an impressive publication portfolio featuring numerous peer-reviewed international articles in respected journals including The Surgeon, BMC Nursing, Scandinavian Journal of Caring Sciences, Journal of PeriAnesthesia Nursing, and Transplant Immunology, exploring vital themes such as organ donation determinants, anxiety and pain management, acupressure interventions, disaster response self-efficacy, and transplant readiness scale development. Her scholarly activity spans mixed-methods studies, randomized controlled trials, descriptive analyses, retrospective research, and methodological scale development, demonstrating her scientific range and depth. She has presented widely at national and international conferences, authored book chapters, and engaged actively in professional organizations such as Türk Hemşireler Derneği and Organ Nakli Hemşireleri Derneği. Additionally, she has contributed to academic governance as Vice Director of the School of Health and served as a thesis jury member at multiple universities. Her diverse teaching portfolio includes courses in surgical nursing, emergency care, transplantation nursing, and nursing education, reflecting her commitment to shaping future generations of healthcare professionals. Ongoing research projects, including technology-enhanced training for nursing students and clinical intervention studies, further emphasize her forward-looking vision. With her strong research productivity, scholarly influence, leadership roles, and clear contributions to nursing science and healthcare improvement, Assoc. Prof. Dr. Dilek Soylu is highly suitable and deserving of recognition through a Best Researcher Award.

Profiles: ORCID | Scopus | ResearchGate

Featured Publications

  1. Soylu, D., & Doğaner, A. (2025). The effect of self-confidence, life satisfaction and death anxiety on organ donation in student nurses: Moderator effect. The Surgeon, 23.

  2. Soylu, A., Seven, A., & Soylu, D. (2025). The impact of training using six thinking hats versus video training on nursing students’ insulin administration skills: A mixed-methods study. BMC Nursing, 24.

  3. Soylu, A., & Soylu, D. (2025). Comparison of pain, anxiety, and comfort level after femoral or transradial angiography: A descriptive study. Journal of PeriAnesthesia Nursing.

  4. Soylu, D., & Soylu, A. (2025). Determination of urinary system infections risk factors after kidney transplantation: Retrospective analysis. Göbeklitepe Sağlık Bilimleri Dergisi, 9(19), 1–7.

  5. Soylu, D. (2025). Self-confidence, communication skills, and a solution-focused approach in organ transplantation coordinators: Descriptive study. Turkish Journal of Surgery, 41(1), 47–55.

Assoc. Prof. Dr. Dilek Soylu’s research advances science and society by strengthening evidence-based practices in surgical nursing, organ transplantation, disaster readiness, and patient-centered care. Her contributions enhance global healthcare quality through innovative training methods, clinical interventions, and multidisciplinary approaches that improve patient outcomes and professional competency. Her work continues to inspire transformative innovation across health professions and contributes meaningfully to the future of global healthcare systems.